Skip to content
healthcare.dev

Sodium Polystyrene Sulfonate

NDC 42806-013, Sodium Polystyrene Sulfonate, powder, for suspension, from Epic Pharma, LLC.

Product NDC
42806-013
Status
Listed
Labeler
Epic Pharma, LLC
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202333
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42806-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM POLYSTYRENE SULFONATE4.1 meq/g
Package NDCNDC-11Package
42806-013-944280600139415 g in 1 BOTTLE (42806-013-94)
42806-013-9642806001396453.6 g in 1 JAR (42806-013-96)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/61cc890b-eb3d-494c-ae45-629a27e721ce
  • NADAC price for package 42806001394

    GET /v1/drugs/nadac/42806001394
  • NADAC price for package 42806001396

    GET /v1/drugs/nadac/42806001396

Use it

Look up 42806-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42806-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42806-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.